Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy

NCT03294109 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03294109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03294109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
June 24, 2020
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

activity, sexual, analgesics, non-narcotic, analgesics, opioid, pain, postoperative, patient satisfaction, peripheral nervous system agents, physiological effects of drugs, return to work